Kern Briggs
Head of U s Operations and Senior Director, Business Partnerships & Strategic Communications @Jcr Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
Head of U s Operations and Senior Director, Business Partnerships & Strategic Communications @Jcr Pharmaceuticals
San Diego, CA, US
Manage business development and negotiations for a mid-size biotechnology company to advance research collaborations and licensing deals for JCR\'s rare disease assets and platform technologies to deliver biologics and gene therapies into the CNS.• Developed, and responsible for executing, the first global strategic communications strategy for JCR to raise the company’s profile outside of Japan and elevate corporate reputation as a thought leader in rare and CNS-related diseases (including neurodegeneration) to support the company\'s globalization, partnership strategy and clinical development.• Transforming the company\'s corporate communications from reactive to proactive across media relations, thought leadership, news flow, patient-focus, and storytelling that has resulted in positive earned media and improved the company\'s reputations.• Led the corporate rebranding of JCR and developed the company\'s first digital media strategy including the design, launch and management of a new global website and JCR\'s first social media platform on LinkedIn.• Initiated and manage a new market access capability and strategy initiative for the company\'s mid-to-late-stage clinical development assets to build capability and support payer/HTA insights generation and application to pivotal trial designs, holistic evidence plans and launch strategies in priority markets.• From July 2024, Head of U.S. Operations. Lead a team and manage subsidiary strategy and day-to-day operations for JCR USA. • https://jcrpharm.com
EDUCATION
The George Washington University
(M.A.) Master of Arts, International Affairs
University of Oregon
(B.A.) Bachelor of Arts, Russian Studies, Sociology
SKILLS
ABOUT KERN BRIGGS
Mission driven with a sense of purpose to advance innovative medicines for rare and genetic diseases for patients and families who are waiting for life-changing treatments. Champion of elevating the patient and caregiver voice throughout all stages of patient-focused drug development and commercialization. Twenty five years of leadership experience in the life sciences across commercial and public affairs leadership roles including business development, launch strategy, commercialization, business negotiations, market access, communications (strategic, corporate, scientific, product), government affairs, patient advocacy, investor relations, and healthcare policy. Proven experience in strategy development and execution, organizational change management, adapting and developing functional capabilities and creating/managing high performing teams to proactively support all stages of development, launch strategy and life-cycle management. Deep therapeutic experience in rare disease, gene therapy, neuroscience, neurodegeneration, Alzheimer\'s, immunology, diabetes, cardio-metabolic, oncology, hematology and gastroenterology. Solid track record on successful product launches and building strategic business partnerships on assets & platform technology. Executed many successful external affairs campaigns that included partnerships with patient advocacy groups to advance clinical trial awareness & recruitment, disease state awareness, education, early diagnosis, and engagement on therapeutic policy/regulatory issues. Highly effective collaborator with internal cross-functional partners. Broad commercial and public affairs experience in over 100 countries including the U.S, Europe, Japan, China and emerging markets.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.